Revelation Biosciences, Inc.
REVB
$0.80
$0.011.27%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 3.70M | 6.50M | 6.54M | 12.07M | 14.55M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 223.30K | 66.70K | 117.80K | 125.70K | 71.90K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 3.93M | 6.57M | 6.66M | 12.20M | 14.62M |
|
|
|||||
| Total Current Assets | 3.93M | 6.57M | 6.66M | 12.20M | 14.62M |
| Net Property, Plant & Equipment | 42.40K | 56.30K | 81.20K | 70.80K | 78.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 3.97M | 6.62M | 6.74M | 12.27M | 14.70M |
|
|
|||||
| Total Accounts Payable | 625.10K | 783.60K | 3.13M | 1.28M | 1.68M |
| Total Accrued Expenses | 463.60K | 1.13M | 934.40K | 8.45M | 620.30K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 800.00 | 2.20K | 4.80K | 1.39M | 2.93M |
| Total Other Current Liabilities | 800.00 | 2.20K | 4.80K | 1.39M | 2.93M |
| Total Current Liabilities | 1.09M | 1.91M | 4.07M | 11.13M | 5.23M |
|
|
|||||
| Total Current Liabilities | 1.09M | 1.91M | 4.07M | 11.13M | 5.23M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 1.09M | 1.91M | 4.07M | 11.13M | 5.23M |
|
|
|||||
| Common Stock & APIC | 45.44M | 45.21M | 41.45M | 37.68M | 37.62M |
| Retained Earnings | -42.56M | -40.51M | -38.78M | -36.54M | -28.15M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 2.88M | 4.71M | 2.67M | 1.14M | 9.47M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 2.88M | 4.71M | 2.67M | 1.14M | 9.47M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 2.88M | 4.71M | 2.67M | 1.14M | 9.47M |
|
|
|||||